Evidence map›Paper›PMID 38253961›Full record

ReviewBritish journal of haematology2024

Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes.

Pearl O Ebea-Ugwuanyi, Sadasivan Vidyasagar, James R Connor, David M Frazer, Mitchell D Knutson, James F Collins

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of haematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Nutrients · 2026
    Article
  12. Iron Deficiency as a Modifiable Risk Factor in Heart Failure: Evidence and Recommendations.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Review
  19. Article
  20. Iron Deficiency Anemia.Advances in experimental medicine and biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Pearl O Ebea-UgwuanyiFood Science & Human Nutrition Department, University of Florida, Gainesville, Florida, USA.ORCID 0009-0005-2879-0475
Sadasivan VidyasagarDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA.
James R ConnorDepartment of Neurosurgery, Penn State College of Medicine, Hershey, Pennsylvania, USA.
David M FrazerMolecular Nutrition Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Mitchell D KnutsonFood Science & Human Nutrition Department, University of Florida, Gainesville, Florida, USA.
James F CollinsFood Science & Human Nutrition Department, University of Florida, Gainesville, Florida, USA.ORCID 0000-0002-8765-0297
University of Florida · USPenn State Milton S. Hershey Medical Center · USQIMR Berghofer Medical Research Institute · AU

Funding

Molecular Mechanisms of Intestinal Metal Ion Transport During Iron-DeficiencyR01DK074867 · NIDDK · UNIVERSITY OF FLORIDA · PI COLLINS, JAMES F., VIDYASAGAR, SADASIVAN · 2007 to 2022
$5.1M
Divalent Metal-ion Transporter 1 as a Therapeutic Target to Optimize Intestinal Iron TransportR01DK109717 · NIDDK · UNIVERSITY OF FLORIDA · PI COLLINS, JAMES F. · 2016 to 2020
$2.6M
NIDDK NIH HHS DK074867NIDDK NIH HHS R01 DK074867NIDDK NIH HHS R01 DK109717
6 · The paper itself

Abstract

Iron deficiency (ID) and iron-deficiency anaemia (IDA) are global public health concerns, most commonly afflicting children, pregnant women and women of childbearing age. Pathological outcomes of ID include delayed cognitive development in children, adverse pregnancy outcomes and decreased work capacity in adults. IDA is usually treated by oral iron supplementation, typically using iron salts (e.g. FeSO

Indexed as

Anemia, Iron-DeficiencyIron DeficienciesIron OverloadAdultChildFemaleHumansIronPregnancyIronanaemiaDMT1FPNhepcidinintestinal iron absorptioniron supplementation

Identifiers

PMID38253961
PMCPMC10939879
OpenAlexW4391115506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.